Furthermore, neither endocan nor E-selectin (Luminex analyses, the first 89 consecutive patients) showed any significant difference when comparing patients with iliac vein thromboses (n = 10) to patients with thromboses only involving the lower veins (p = 0.19 and p = 0.87 respectively). This evidence concerns the gene SELE and thrombotic disease.